| Literature DB >> 26565914 |
Thomas Bertero1, Katherine A Cottrill1, Yu Lu1, Christina M Haeger2, Paul Dieffenbach2, Sofia Annis1, Andrew Hale1, Balkrishen Bhat3, Vivek Kaimal3, Ying-Yi Zhang1, Brian B Graham4, Rahul Kumar4, Rajan Saggar5, Rajeev Saggar6, W Dean Wallace5, David J Ross5, Stephen M Black7, Sohrab Fratz8, Jeffrey R Fineman9, Sara O Vargas10, Kathleen J Haley2, Aaron B Waxman2, B Nelson Chau3, Laura E Fredenburgh2, Stephen Y Chan11.
Abstract
Pulmonary hypertension (PH) is a deadly vascular disease with enigmatic molecular origins. We found that vascular extracellular matrix (ECM) remodeling and stiffening are early and pervasive processes that promote PH. In multiple pulmonary vascular cell types, such ECM stiffening induced the microRNA-130/301 family via activation of the co-transcription factors YAP and TAZ. MicroRNA-130/301 controlled a PPAR?-APOE-LRP8 axis, promoting collagen deposition and LOX-dependent remodeling and further upregulating YAP/TAZ via a mechanoactive feedback loop. In turn, ECM remodeling controlled pulmonary vascular cell crosstalk via such mechanotransduction, modulation of secreted vasoactive effectors, and regulation of associated microRNA pathways. In vivo, pharmacologic inhibition of microRNA-130/301, APOE, or LOX activity ameliorated ECM remodeling and PH. Thus, ECM remodeling, as controlled by the YAP/TAZ-miR-130/301 feedback circuit, is an early PH trigger and offers combinatorial therapeutic targets for this devastating disease.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26565914 PMCID: PMC4644508 DOI: 10.1016/j.celrep.2015.09.049
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423